6 investors discuss why AI is more than just a buzzword in biotech
TechCrunch
DECEMBER 15, 2022
VCs are also increasingly looking for what biotech startups can do with AI beyond just R&D and are wary of companies that use the technology as a marketing tool. Have declines in the public-market valuations of biotech companies impacted your investments in the sector? The survey also covers the implications of U.S
Let's personalize your content